Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Completed 9Withdrawn 3Unknown 2Recruiting 2Active not recruiting 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Lymphoid 1Gynecologic 1Dermatologic 1

Conditions

Vascular Malformations 1Uterine Cervical Dysplasia 1Lymphoma, T-Cell, Cutaneous 1Hemangioma, Capillary 1Hemangioma 1

Interventions

Cyclophosphamide 129Cisplatin 119Radiotherapy 115pembrolizumab 111Carboplatin 97Paclitaxel 96Gemcitabine 96Magnetic Resonance Spectroscopy 80Nivolumab 76Bevacizumab 76Fluorouracil 74Dexamethasone 73Radiosurgery 66Docetaxel 59Rituximab 58Leucovorin 57Oxaliplatin 55Capecitabine 55Biopsy 53Doxorubicin 52fludarabine 51Drug Therapy 45durvalumab 44Cytarabine 44Etoposide 42fludarabine phosphate 40Pemetrexed 40Radiation 39atezolizumab 36Surveys and Questionnaires 36

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Withdrawn × Ointments × Clear all
NCT03143491 2017-10-18

Study of SOR007 Ointment for Cervical Intraepithelial Neoplasia (CIN)

DFB Soria, LLC

Phase 2 Withdrawn
Gynecologic

Uterine Cervical Dysplasia

NCT01843998 2015-06-04

Therapeutic Efficacy of Topical Sirolimus in Early Stage Cutaneous T-cell Lymphoma (CTCL)

Medical College of Wisconsin

Phase 2 Withdrawn
DermatologicLymphoid

Lymphoma, T-Cell, Cutaneous

NCT01408056 2014-01-17

TOUCH

Children's Hospital of Philadelphia

Phase 2 Withdrawn

Hemangioma, Hemangioma, Capillary, Vascular Malformations

Data powered by HemOnc (CC BY 4.0) Colophon âš¡